logo

Cerebral Somatic Oximeters Market Size (2024 - 2029)

The cerebral somatic oximeters market is projected to experience significant expansion over the forecast period, driven by the increasing prevalence of neurological disorders and the rising adoption of these devices in developed regions. The demand is further bolstered by the routine use of cerebral oximetry in neonatal intensive care units and its application in monitoring brain and cardiac conditions. Despite these growth drivers, the market's expansion may be hindered by the high costs associated with the devices due to their expensive sensors.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Clinical Diagnostic Laboratory Equipment Research Disease Specific Diagnostic Devices Research Hematology Diagnostics Research Cerebral Somatic Oximeters Market Market Size

Market Size of Cerebral Somatic Oximeters Industry

Cerebral Somatic Oximeters Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 191.21 Million
Market Size (2029) USD 258.30 Million
CAGR (2024 - 2029) 6.23 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Cerebral Somatic Oximeters Market Major Players

*Disclaimer: Major Players sorted in no particular order

Cerebral Somatic Oximeters Market Analysis

The Cerebral Somatic Oximeters Market size is estimated at USD 191.21 million in 2024, and is expected to reach USD 258.30 million by 2029, growing at a CAGR of 6.23% during the forecast period (2024-2029).

  • The market for cerebral somatic oximeters is expected to witness healthy growth during the forecast period. This is majorly attributed to the rising incidence of neurological diseases and the growing adoption of cerebral oximeters in developed economies such as North America and Europe.
  • According to an article published in the National Center for Biotechnology Information (NCBI) in April 2022, hypoxic-ischemic encephalopathy (HIE) is reported in one to six per 1,000 live births in developed countries and 26 per 1,000 live births in developing countries. The high burden of such neurological diseases propels the demand for cerebral somatic oximeters to detect the oxygen levels in the brain, thereby boosting market growth.
  • In addition, cerebral oximetry is used routinely in some neonatal intensive care units (NICUs). For instance, as per an article published in Frontiers in Pediatrics Journal in April 2022, cerebral oximetry is utilized in the context of cardiac surgery and is used almost universally as a clinical routine in the perioperative care of newborn infants with congenital heart disease and neonatology. As per the article, a clinical trial is currently ongoing to assess the importance of cerebral oximetry in severe brain injury in the neonatal department. The rising research studies are expected to propel the utility of cerebral somatic oximeters in the detection of oxygen levels of various brain and cardiac diseases during the forecast period.
  • Therefore, owing to the aforementioned factors, such as the high burden of neurological diseases and technologically advanced product approvals, the cerebral somatic oximeters market is anticipated to witness growth during the forecast period. However, the high cost of the device due to the expensive sensors used in the cerebral oximeters is estimated to restrain the market’s growth.

Cerebral Somatic Oximeters Industry Segmentation

Cerebral oximeters enable continuous non-invasive monitoring of cerebral oxygenation and utilize similar physical principles to pulse oximeters.

The cerebral somatic oximeters market is segmented by type, application, end-user, patient type, and geography. By type, the market is segmented as dual emitter and dual detector, single emitter and dual detector, and other types. By application, the market is segmented into cardiac surgery, vascular surgery, and other applications. By end user, the market is segmented as hospitals and clinics, ambulatory surgical centers, and other end users. By patient type, the market is segmented into pediatrics and adults. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.

The report offers the value (USD) for the above segments.

By Type
Dual Emitter and Dual Detector
Single Emitter and Dual Detector
Other Types
By Application
Cardiac Surgery
Vascular Surgery
Other Applications
By Patient Type
Pediatrics
Adults
By End User
Hospitals and Clinics
Ambulatory Surgical Centers
Other End Users
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Cerebral Somatic Oximeters Market Size Summary

The cerebral somatic oximeters market is poised for significant growth over the forecast period, driven by the increasing prevalence of neurological diseases and the expanding use of these devices in developed regions like North America and Europe. The demand for cerebral somatic oximeters is bolstered by their critical role in monitoring brain oxygen levels, particularly in neonatal intensive care units and during cardiac surgeries. The rising incidence of conditions such as hypoxic-ischemic encephalopathy and the routine use of cerebral oximetry in cardiac procedures underscore the technology's importance in both clinical and research settings. However, the high cost of these devices, attributed to the expensive sensors they employ, poses a challenge to market expansion.

North America is expected to maintain a substantial share of the market, supported by a robust healthcare infrastructure, a growing elderly population, and a high incidence of neurological and cardiovascular diseases. The region's market growth is further fueled by significant research investments and the presence of key industry players. The market is moderately consolidated, with major companies like Masimo, Medtronic PLC, and GE Healthcare Inc. leading the charge in innovation and strategic partnerships. These companies are actively developing and launching new products to enhance their competitive edge, while also engaging in collaborations to integrate advanced monitoring technologies. As a result, the cerebral somatic oximeters market is anticipated to experience steady growth, driven by technological advancements and increasing clinical applications.

Explore More

Cerebral Somatic Oximeters Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Incrreasing Adoption of the Cerebral Oximeters

      2. 1.2.2 Rising Incidence of Neurological Diseases

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of the Device

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Type

      1. 2.1.1 Dual Emitter and Dual Detector

      2. 2.1.2 Single Emitter and Dual Detector

      3. 2.1.3 Other Types

    2. 2.2 By Application

      1. 2.2.1 Cardiac Surgery

      2. 2.2.2 Vascular Surgery

      3. 2.2.3 Other Applications

    3. 2.3 By Patient Type

      1. 2.3.1 Pediatrics

      2. 2.3.2 Adults

    4. 2.4 By End User

      1. 2.4.1 Hospitals and Clinics

      2. 2.4.2 Ambulatory Surgical Centers

      3. 2.4.3 Other End Users

    5. 2.5 By Geography

      1. 2.5.1 North America

        1. 2.5.1.1 United States

        2. 2.5.1.2 Canada

        3. 2.5.1.3 Mexico

      2. 2.5.2 Europe

        1. 2.5.2.1 Germany

        2. 2.5.2.2 United Kingdom

        3. 2.5.2.3 France

        4. 2.5.2.4 Italy

        5. 2.5.2.5 Spain

        6. 2.5.2.6 Rest of Europe

      3. 2.5.3 Asia-Pacific

        1. 2.5.3.1 China

        2. 2.5.3.2 Japan

        3. 2.5.3.3 India

        4. 2.5.3.4 Australia

        5. 2.5.3.5 South Korea

        6. 2.5.3.6 Rest of Asia-Pacific

      4. 2.5.4 Middle East and Africa

        1. 2.5.4.1 GCC

        2. 2.5.4.2 South Africa

        3. 2.5.4.3 Rest of Middle East and Africa

      5. 2.5.5 South America

        1. 2.5.5.1 Brazil

        2. 2.5.5.2 Argentina

        3. 2.5.5.3 Rest of South America

Cerebral Somatic Oximeters Market Size FAQs

The Cerebral Somatic Oximeters Market size is expected to reach USD 191.21 million in 2024 and grow at a CAGR of 6.23% to reach USD 258.30 million by 2029.

In 2024, the Cerebral Somatic Oximeters Market size is expected to reach USD 191.21 million.

Cerebral Somatic Oximeters Market Report Snapshots

Cerebral Somatic Oximeters Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)